Synthesis 2005(1): 109-121  
DOI: 10.1055/s-2004-834913
PAPER
© Georg Thieme Verlag Stuttgart · New York

Primary and Secondary Allyltitanium(IV) Reagents in Aldehyde Allylation II: Application to an Enantioselective Preparation of a C1-C7 Fragment of Spiramycin

Patrick Razon, Marie-Ange N’Zoutani, Sylvie Dhulut, Sophie Bezzenine-Lafollée, Ange Pancrazi, Janick Ardisson*
Laboratoire de Synthèse Organique Sélective et Chimie Organométallique, CNRS-UCP-ESCOM, UMR 8123, ESCOM, Bat E, 13 Bd de l’Hautil, 95092 Cergy-Pontoise, France
Fax: +33(1)307561; e-Mail: janick.ardisson@chim.u-cergy.fr;
Further Information

Publication History

Received 3 August 2004
Publication Date:
08 December 2004 (online)

Abstract

A synthetic approach to the eastern part of spiramycin, an important antibiotic compound, is described. Introduction of the side chain was first envisaged through a Hoppe aldehyde allylation. This reaction was carried out between an optically pure aldehyde 32 and a (±)-γ-alkoxy allyltitanium(IV) species derived from a primary γ-alkoxy allyl (diisopropyl)carbamate. Under kinetic resolution conditions, the anti-Cram compound 35 was obtained in an 80:20 mixture, with the Cram isomer 34, in 81% yield. Employing the optically pure (S)-γ-alkoxy allyl (diisopropyl)carbamate 36, the corresponding (R)-γ-alkoxy allyltitanium (R)-‘Ti’-III was generated under n-BuLi·TMEDA/Ti(Oi-Pr)4 conditions, that reacted with aldehyde 32 in double stereodifferentiation to deliver the expected Cram compound 40 in 80% yield (95% de). This latter corresponded to the C1-C7 fragment of spiramycin.

10

The structure of 36 was established by comparison of its 1H and 13C NMR spectra with those of compound 46. Analysis of 1H and 13C NMR spectra was supported by 2D experiments.